FdaApplication
BLA 761100
Identifiers
- fda_app_no: BLA761100
Properties
| Property | Value |
|---|---|
| applicant_name | Samsung Bioepis Co., Ltd. |
| application_type | BLA |
| approval_date | 2019-01-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ONTRUZANT | TRASTUZUMAB-DTTB | 420MG | For Injection |
| ONTRUZANT | TRASTUZUMAB-DTTB | 150MG | For Injection |
2 products